Another study reported that the baseline expression levels of IFN-related genes, such as EPSTI1, IFI44 L, LY6E, OAS3, and RSAD2, are sufficient to predict flares and outcomes in SLE patients (44), but they may not be feasible for use in daily clinical practice. This evidence concerns the gene RSAD2 and systemic lupus erythematosus.